Many molecular regulators, such as microRNAs, transcription factors, and kinases have been reported to mediate the silencing or overexpression of NANOG through post-transcriptional and translational regulation and thus regulate stemness and malignant transformation, as well as CSC-like phenotypes in cancer cells (50, 87, 88). This evidence concerns the gene NANOG and cancer.